5 Must-Read Analyst Questions From Addus HomeCare's Q1 Earnings Call

Addus HomeCare’s first quarter results were well received by the market, with management highlighting robust growth in its Personal Care segment and successful integration of its largest-ever acquisition, Gentiva. CEO Dirk Allison credited strong caregiver hiring and a 5.5% rate increase in Illinois as key drivers, while President Brad Bickham noted operational improvements in scheduling and service fulfillment. The company also benefited from targeted use of American Rescue Plan Act funds to support recruitment and retention in New Mexico. Management did not express caution or uncertainty regarding the quarter’s results.

Is now the time to buy ADUS? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions Addus HomeCare’s Q1 Earnings Call

• Ben Hendrix (RBC Capital Markets) inquired about potential Medicare Cap limitations in hospice. President Brad Bickham responded that the impact was immaterial, crediting balanced referral mix and recent sales leadership changes.
• Joanna Gajuk (Bank of America) questioned the sustainability of Personal Care volume growth after weather-related headwinds. Bickham confirmed that growth rebounded in February and March, expecting hours growth to remain in the 2%–2.5% range.
• Tao Qiu (Macquarie) asked about margin cadence following the Gentiva acquisition. CFO Brian Poff explained that Q1 is typically the lowest margin quarter, with sequential improvement expected as payroll tax caps are reached and operational synergies take hold.
• Matthew Gillmor (KeyBanc) sought insight into Gentiva’s performance versus expectations. Bickham said bottom-line performance was stronger than projected, with top line slightly lighter due to the timing of Medicaid redetermination in Texas.
• Jared Haase (William Blair) asked about workforce retention trends across service lines and at Gentiva. Bickham noted industry-wide improvement since the pandemic, with ongoing challenges in clinical hiring but significant progress in Personal Care retention.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will be watching (1) further integration and financial contribution from the Gentiva acquisition, (2) legislative outcomes in Texas and other key states regarding Medicaid rate increases, and (3) operational benefits from the rollout of workforce management technology across more states. Progress on additional acquisitions and sustained margin expansion will also be key markers of execution.

Addus HomeCare currently trades at $115.64, up from $104.37 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.

While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.